Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia

Bibliographic Details
Main Authors:	Nakamura Yusuke, Yamano Yoshihisa, Utsunomiya Atae, Sato Tomoo, Araya Natsumi, Senkoji Naomi, Osawa Ayako, Ishihara Makoto, Ueda Koji, Nakagawa Hidewaki
Format:	Article
Language:	English
Published:	BMC 2011-06-01
Series:	Retrovirology

Similar Items

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
by: Tomoo Sato, et al.
Published: (2018-07-01)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
by: Shuntaro Tsutsumi, et al.
Published: (2019-10-01)

CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
by: Tomoo Sato, et al.
Published: (2013-01-01)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Keiko Tamaki, et al.
Published: (2019-09-01)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
by: Yoshihisa Yamano, et al.
Published: (2011-08-01)

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Reza Boostani, et al.
Published: (2019-05-01)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Alvaro Schwalb, et al.
Published: (2020-06-01)

Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.
by: Satoshi Nozuma, et al.
Published: (2014-01-01)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Natsuko Yamakawa, et al.
Published: (2020-07-01)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Taylor Graham P, et al.
Published: (2011-06-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
by: Satoshi Nozuma, et al.
Published: (2016-01-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Stumpf Michael PH, et al.
Published: (2011-10-01)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Satoshi Nozuma, et al.
Published: (2017-04-01)

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
by: Daisuke Kodama, et al.
Published: (2020-07-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Overlapping Ossification of the Ligamentum Flavum
by: Guilherme Gago, et al.
Published: (2020-09-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Yoshimi Enose-Akahata, et al.
Published: (2019-11-01)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
by: Seino Ken-ichiro, et al.
Published: (2011-06-01)

Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis
by: José Vicente Pereira Martins, et al.
Published: (2012-04-01)

Proprioceptive neuromuscular facilitation in HTLV-I-associated myelopathy/tropical spastic paraparesis
by: Vera Lúcia Santos de Britto, et al.
Published: (2014-01-01)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
by: Marco Baratella, et al.
Published: (2017-01-01)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
by: Houshang Rafatpanah, et al.
Published: (2013-03-01)

The Relevance of HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis in Iran: A Review Study
by: Masoud Keikha, et al.
Published: (2019-06-01)

Clinical pathophysiology of human T-lymphotropic virus-type1-associated myelopathy/tropical spastic paraparesis
by: Yoshihisa eYamano, et al.
Published: (2012-11-01)

High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1
by: J. Primo, et al.
Published: (2009-08-01)

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
by: Larissa Deadame de Figueiredo Nicolete, et al.
Published: (2012-09-01)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
by: Jacobson Steven, et al.
Published: (2011-06-01)

Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Abelardo Q-C Araújo, et al.
Published: (1993-09-01)

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
by: Gabriel Andrade Nonato Queiroz, et al.
Published: (2019-05-01)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
by: Mohadeseh Zarei-Ghobadi, et al.
Published: (2021-03-01)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
by: Mahieux Renaud, et al.
Published: (2008-10-01)

Pregnancy complicated by HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP): a case report
by: Hiroshi Mori, et al.
Published: (2021-07-01)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
by: Graça Maria de Castro Viana, et al.
Published: (2014-09-01)

HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission.
by: Everton S Batista, et al.
Published: (2019-12-01)

Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis.
by: Fabiola Martin, et al.
Published: (2012-01-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
by: Antonio C. R. Vallinoto, et al.
Published: (2015-01-01)

Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?
by: Jorge Casseb
Published: (2009-01-01)

Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia Virus Type 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
by: Mineki Saito
Published: (2010-01-01)

Tropical spastic paraparesis / HTLV-associated myelopathy (TSP/HAM). Case reports in Colombian pacific coast
by: Alonso Arturo Ruíz-Perea, et al.
Published: (2013-09-01)

Tropical spastic paraparesis / HTLV-associated myelopathy (TSP/HAM). Case reports in Colombian pacific coast
by: Alonso Arturo Ruíz-Perea, et al.
Published: (2013-09-01)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
by: Jacobson Steven, et al.
Published: (2011-06-01)

Cannot write session to /tmp/vufind_sessions/sess_sefc5rme6ehv2e62c3124q59ju